LAVA Therapeutics NV (LAVA Therapeutics NV) Receivables Turnover : 6.37 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. LAVA Therapeutics NV's Revenue for the three months ended in Mar. 2024 was $6.99 Mil. LAVA Therapeutics NV's average Accounts Receivable for the three months ended in Mar. 2024 was $1.10 Mil. Hence, LAVA Therapeutics NV's Receivables Turnover for the three months ended in Mar. 2024 was 6.37.

LAVA Therapeutics NV Receivables Turnover Historical Data

The historical data trend for LAVA Therapeutics NV's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Receivables Turnover Chart

LAVA Therapeutics NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

6.20

7.12

10.72

2.87

LAVA Therapeutics NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial													0.46	1.71	0.02	0.28	6.37

Competitive Comparison of LAVA Therapeutics NV's Receivables Turnover

For the Biotechnology subindustry, LAVA Therapeutics NV's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LAVA Therapeutics NV's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LAVA Therapeutics NV's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where LAVA Therapeutics NV's Receivables Turnover falls into.

LAVA Therapeutics NV Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

LAVA Therapeutics NV's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	6.769	/ (	(3.254	+	1.459)	/	2 )
=	6.769	/	2.3565
=	2.87

LAVA Therapeutics NV's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

	Receivables Turnover (Q: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Mar. 2024 ))	/	count )
=	6.992	/ (	(1.459	+	0.737)	/	2 )
=	6.992	/	1.098
=	6.37

LAVA Therapeutics NV (NAS:LVTX) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

LAVA Therapeutics NV Receivables Turnover Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

4PKB:Germany

Address

Yalelaan 62, Utrecht, UT, NLD, 3584 CM

Website

https://www.lavatherapeutics.com

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.